$19.8 Billion is the total value of Polar Capital Holdings Plc's 286 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ATLASSIAN CORPORATIONcall | $1,720,320,996 | -2.0% | 10,251,600 | 0.0% | 8.68% | -23.9% | ||
VRTX | VERTEX PHARMACEUTICALS INC | $131,966,250 | +11.7% | 375,000 | 0.0% | 0.67% | -13.2% | |
RVNC | REVANCE THERAPEUTICS INC | $105,488,081 | -21.4% | 4,167,842 | 0.0% | 0.53% | -39.0% | |
RE | EVEREST RE GROUP LTD | $95,720,800 | -4.5% | 280,000 | 0.0% | 0.48% | -25.8% | |
REGN | REGENERON PHARMACEUTICALS | $95,206,550 | -12.6% | 132,500 | 0.0% | 0.48% | -32.1% | |
ALKS | ALKERMES PLC | $90,394,901 | +11.0% | 2,888,016 | 0.0% | 0.46% | -13.8% | |
EXEL | EXELIXIS INC | $63,462,361 | -1.5% | 3,320,898 | 0.0% | 0.32% | -23.6% | |
RYAN SPECIALTY HOLDINGS INCcl a | $59,479,250 | +11.6% | 1,325,000 | 0.0% | 0.30% | -13.3% | ||
FAF | FIRST AMERN FINL CORP | $54,169,000 | +2.4% | 950,000 | 0.0% | 0.27% | -20.4% | |
SNY | SANOFIsponsored adr | $53,900,000 | -1.0% | 1,000,000 | 0.0% | 0.27% | -22.9% | |
HAGERTY INC | $42,884,759 | +7.1% | 4,581,705 | 0.0% | 0.22% | -16.9% | ||
APLS | APELLIS PHARMACEUTICALS INC | $42,361,500 | +38.1% | 465,000 | 0.0% | 0.21% | +7.5% | |
MMSI | MERIT MED SYS INC | $40,894,022 | +13.1% | 488,929 | 0.0% | 0.21% | -12.3% | |
BMRN | BIOMARIN PHARMACEUTICAL INC | $36,839,000 | -10.9% | 425,000 | 0.0% | 0.19% | -30.6% | |
AFL | AFLAC INC | $36,296,000 | +8.2% | 520,000 | 0.0% | 0.18% | -16.1% | |
INSM | INSMED INC | $35,687,464 | +23.8% | 1,691,349 | 0.0% | 0.18% | -3.7% | |
RLI | RLI CORP | $35,482,200 | +2.7% | 260,000 | 0.0% | 0.18% | -20.1% | |
ADUS | ADDUS HOMECARE CORP | $35,217,935 | -13.2% | 379,913 | 0.0% | 0.18% | -32.3% | |
PRA | PROASSURANCE CORP | $32,632,125 | -18.3% | 2,162,500 | 0.0% | 0.16% | -36.5% | |
NUTANIX INCnote 0.250%10/0 | $30,631,006 | +1.5% | 36,010,000 | 0.0% | 0.16% | -20.9% | ||
ITCI | INTRA-CELLULAR THERAPIES INC | $25,328,000 | +16.9% | 400,000 | 0.0% | 0.13% | -9.2% | |
DCPH | DECIPHERA PHARMACEUTICALS IN | $24,640,000 | -8.9% | 1,750,000 | 0.0% | 0.12% | -29.5% | |
MRUS | MERUS N V | $19,747,500 | +43.1% | 750,000 | 0.0% | 0.10% | +11.1% | |
BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $16,938,010 | -4.3% | 17,200,000 | 0.0% | 0.08% | -26.1% | ||
BKR | BAKER HUGHES COMPANYcl a | $10,641,759 | +9.5% | 336,658 | 0.0% | 0.05% | -14.3% | |
SYK | STRYKER CORPORATION | $9,622,234 | +6.9% | 31,539 | 0.0% | 0.05% | -15.5% | |
ROK | ROCKWELL AUTOMATION INC | $8,433,261 | +12.3% | 25,598 | 0.0% | 0.04% | -12.2% | |
WMT | WALMART INC | $8,243,148 | +6.6% | 52,444 | 0.0% | 0.04% | -16.0% | |
MU | MICRON TECHNOLOGY INC | $6,851,095 | +4.6% | 108,558 | 0.0% | 0.04% | -18.6% | |
BENTLEY SYS INCnote 0.375% 7/0 | $6,810,000 | +6.9% | 7,500,000 | 0.0% | 0.03% | -17.1% | ||
SPLUNK INCnote 1.125% 9/1 | $6,516,250 | +3.3% | 6,500,000 | 0.0% | 0.03% | -19.5% | ||
AMGN | AMGEN INC | $5,193,492 | -8.2% | 23,392 | 0.0% | 0.03% | -29.7% | |
EMR | EMERSON ELEC CO | $4,702,721 | +3.7% | 52,027 | 0.0% | 0.02% | -17.2% | |
MOBILEYE GLOBAL INC | $4,556,304 | -11.2% | 118,592 | 0.0% | 0.02% | -30.3% | ||
MACOM TECH SOLUTIONS HLDGS Inote 0.250% 3/1 | $4,060,000 | -3.9% | 4,000,000 | 0.0% | 0.02% | -25.9% | ||
PATRICK INDS INCnote 1.750%12/0 | $2,928,000 | +7.5% | 3,000,000 | 0.0% | 0.02% | -16.7% | ||
ENCORE CAP EUROPE FIN LTDnote 4.500% 9/0 | $2,503,125 | -6.0% | 2,250,000 | 0.0% | 0.01% | -23.5% | ||
MIDDLEBY CORPnote 1.000% 9/0 | $2,181,375 | +0.1% | 1,750,000 | 0.0% | 0.01% | -21.4% | ||
ASPEN TECHNOLOGY INC | $2,058,586 | -26.8% | 12,282 | 0.0% | 0.01% | -44.4% | ||
SNAP INCnote 0.750% 8/0 | $1,759,875 | +0.7% | 1,900,000 | 0.0% | 0.01% | -18.2% | ||
EVH | EVOLENT HEALTH INCcl a | $1,414,192 | -6.6% | 46,673 | 0.0% | 0.01% | -30.0% | |
FTCH | FARFETCH LTDord sh cl a | $697,940 | +23.0% | 115,553 | 0.0% | 0.00% | 0.0% | |
ATRC | ATRICURE INC | $760,884 | +19.1% | 15,415 | 0.0% | 0.00% | 0.0% | |
QUIDELORTHO CORP | $859,673 | -7.0% | 10,375 | 0.0% | 0.00% | -33.3% | ||
APTV | APTIV PLC | $510,450 | -9.0% | 5,000 | 0.0% | 0.00% | -25.0% | |
LI AUTO INCnote 0.250% 5/0 | $684,000 | +22.8% | 500,000 | 0.0% | 0.00% | -25.0% | ||
BRKR | BRUKER CORP | $441,672 | -6.2% | 5,975 | 0.0% | 0.00% | -33.3% | |
TNDM | TANDEM DIABETES CARE INC | $275,093 | -39.6% | 11,210 | 0.0% | 0.00% | -66.7% | |
FLDM | STANDARD BIOTOOLS INC | $193,000 | -1.0% | 100,000 | 0.0% | 0.00% | 0.0% | |
OMCL | OMNICELL COM | $262,855 | +25.6% | 3,568 | 0.0% | 0.00% | 0.0% | |
STXS | STEREOTAXIS INC | $117,331 | -25.0% | 76,687 | 0.0% | 0.00% | 0.0% | |
CSTL | CASTLE BIOSCIENCES INC | $183,821 | -39.6% | 13,398 | 0.0% | 0.00% | -50.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-12-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MICROSOFT CORP | 12 | Q3 2023 | 5.8% |
APPLE INC | 12 | Q3 2023 | 4.7% |
ALPHABET INC | 12 | Q3 2023 | 3.3% |
NVIDIA CORPORATION | 12 | Q3 2023 | 5.4% |
ALPHABET INC | 12 | Q3 2023 | 3.0% |
ADVANCED MICRO DEVICES INC | 12 | Q3 2023 | 2.7% |
META PLATFORMS INC | 12 | Q3 2023 | 3.3% |
ARCH CAP GROUP LTD | 12 | Q3 2023 | 2.5% |
AMAZON COM INC | 12 | Q3 2023 | 2.3% |
CHUBB LIMITED | 12 | Q3 2023 | 1.9% |
View Polar Capital Holdings Plc's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Aeglea BioTherapeutics, Inc. | July 28, 2023 | 3,936,198 | 5.0% |
INFINITY PHARMACEUTICALS, INC. | February 14, 2023 | 2,071,242 | 2.3% |
Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
Summit Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
BELLUS Health Inc. | February 14, 2022 | 2,500,000 | 2.4% |
Oxford Immunotec Global PLCSold out | February 14, 2022 | 0 | 0.0% |
View Polar Capital Holdings Plc's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G | 2024-02-13 |
SC 13G | 2024-02-13 |
13F-HR/A | 2023-12-13 |
13F-HR/A | 2023-12-13 |
View Polar Capital Holdings Plc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.